Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial

Update of EULAR recommendations for the treatment of systemic sclerosis

(2016) Otylia Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis

(2015) T. Hua-Huy et al.   PATHOLOGIE BIOLOGIE

Early Systemic Sclerosis: Analysis of the Disease Course in Patients With Marker Autoantibody and/or Capillaroscopic Positivity

(2014) Gabriele Valentini et al.   ARTHRITIS CARE & RESEARCH

Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

(2013) Tünde Minier et al.   ANNALS OF THE RHEUMATIC DISEASES

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

(2013) Lenny van Bon et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway

(2013) Xiaojing Xing et al.   PLoS One

Very earlyversusearlydisease: the evolving definition of the ‘many faces’ of systemic sclerosis

(2012) Marco Matucci-Cerinic et al.   ANNALS OF THE RHEUMATIC DISEASES

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study

(2012) Vanessa Smith et al.   ANNALS OF THE RHEUMATIC DISEASES

The Immune Pathogenesis of Scleroderma: Context Is Everything

(2012) Matthew B. Greenblatt et al.   Current Rheumatology Reports

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

(2011) B. W. Higgs et al.   ANNALS OF THE RHEUMATIC DISEASES

Therapy of polymyositis and dermatomyositis

(2011) Isabelle Marie et al.   AUTOIMMUNITY REVIEWS

Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

(2011) S A Greenberg et al.   GENES AND IMMUNITY

The Pathogenesis of Systemic Sclerosis Revisited

(2010) Matthias Geyer et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

(2010) Timothy R D J Radstake et al.   NATURE GENETICS

Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory

(2010) L. Czirjak et al.   RHEUMATOLOGY

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

(2009) O Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Innate immunity and inflammation in systemic sclerosis

(2009) Robert Lafyatis et al.   CURRENT OPINION IN RHEUMATOLOGY

Autologous stem cell transplantation improves microcirculation in systemic sclerosis

(2008) I Miniati et al.   ANNALS OF THE RHEUMATIC DISEASES